Evidence map›Paper›PMID 37084071›Full record

ArticleRadiological physics and technology2023

Helical tomotherapy and two types of volumetric modulated arc therapy: dosimetric and clinical comparison for several cancer sites.

Elena Gallio, Anna Sardo, Serena Badellino, Cristina Mantovani, Mario Levis, Christian Fiandra, Alessia Guarneri, Francesca Arcadipane, Veronica Richetto, Umberto Ricardi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elena GallioMedical Physics Unit, A.O.U. Città della Salute e della Scienza, Corso Bramante 88/90, 10126, Turin, TO, Italy. egallio@cittadellasalute.to.it.ORCID http://orcid.org/0000-0003-1388-061X
Anna SardoMedical Physics Unit, A.O.U. Città della Salute e della Scienza, Corso Bramante 88/90, 10126, Turin, TO, Italy.
Serena BadellinoDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Cristina MantovaniDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Mario LevisDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Christian FiandraDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Alessia GuarneriDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Francesca ArcadipaneDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Veronica RichettoMedical Physics Unit, A.O.U. Città della Salute e della Scienza, Corso Bramante 88/90, 10126, Turin, TO, Italy.
Umberto RicardiDepartment of Oncology, University of Turin, Via Santena 5 Bis, 10126, Turin, TO, Italy.
Francesca Romana GiglioliMedical Physics Unit, A.O.U. Città della Salute e della Scienza, Corso Bramante 88/90, 10126, Turin, TO, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy accelerators have undergone continuous technological developments. We investigated the differences between Radixact™ and VMAT treatment plans. Sixty patients were included in this study. Dosimetric comparison between the Radixact™ and VMAT plans was performed for six cancer sites: whole-brain, head and neck, lymphoma, lung, prostate, and rectum. The VMAT plans were generated with two Elekta linear accelerators (Synergy

Indexed as

NeoplasmsRadiotherapy, Intensity-ModulatedHumansMaleOrgans at RiskProstateRadiotherapy DosageRadiotherapy Planning, Computer-AssistedDose comparisonLinacRadixact™TomotherapyVMAT

Identifiers

PMID37084071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.